Business Development for the Biotechnology and Pharmaceutical Industry
Contents:
Sep 27, Paula Salme Sandrak rated it it was ok. People in the industry, however, probably read more complex approaches and theories or just learn by doing.
Tooling Up: The Business Development Career Track
From my perspective a biobiz student , it was educational but boring to read except for a few real-life business cases that spiced things up. A strange mix of easy-going experienced business man talk and coercive bureaucratic legal lingo which, for me, didn't play out so well plus, the book is yearning for a proper editor! The author pointed out the need for overarching knowledge in business development to have various frames of reference but perhaps that's the thing - it lacked brain-twisting insight for me.
I bet there are some eye-popping stories he could share but, I'm telling you, this guy must be hiding something given his scope of experience. Gustavo Rivera rated it really liked it Aug 19, Jackson rated it did not like it Apr 23, Mariam Mikhail rated it it was amazing Mar 01, Terry rated it it was ok Apr 07, Michael Cruse rated it it was ok Apr 16, Cai rated it liked it Jan 07, Greg Endicott rated it liked it Dec 11, Cyprien rated it liked it Sep 19, Audrey marked it as to-read Jun 13, Denise marked it as to-read Sep 26, Lauri Kettunen marked it as to-read Jan 31, Ayushmaan marked it as to-read Jun 22, Fergal Delaney marked it as to-read Dec 12, There are no discussion topics on this book yet.
Books by Martin Austin. I am in the midst of another based in China as I write this in early Two out of the four were Ph. All four candidates originated from the region two Singaporean and two Chinese and all had the required fluent Mandarin and English. Incidentally all four were male as were most of the unsuccessful candidates highlighting an area still lagging behind other departments in terms of equality.
These skills are still in demand but now coupled with more technical knowledge. This type of technical skillset is scarce in Asia and has had an all too predictable inflationary effect.
The candidates know they are in demand, so any enticements to leave their current positions must be significant, often including a much higher wage. The fixed salary increases of the four hires were 14 percent, 26 percent, 33 percent and 37 percent.
Three of the four involved paying expatriate packages, two required significant unvested shares buyout, and one had a generous sign-on bonus to secure the deal. These hires are expensive but clearly considered a critical asset in staying ahead of the competition.
Library of Congress Cataloging-in-Publication Data. Austin, Martin. Business development for the biotechnology and pharmaceutical industry / by Martin Austin. Business Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that.
Today's pharma industry demands that business development professionals continually scout other industries and nontraditional players when seeking disruptive technologies that could be used to aid product innovation, expansion, and revenue growth. For example, the use of additive manufacturing AM is increasing in the med-tech industry.
Three Crucial Questions to Answer About Your M&A Strategy
AM offers the potential for better patient access to life-changing medical devices and lower supply chain and production costs. The med-tech industry already accounts for close to 20 percent of the AM market. Another is mobile health mHealth , which is changing the way healthcare is delivered, improving patient engagement, and simplifying payments.
Of course, there is always artificial intelligence AI , which has a huge potential for impacting healthcare. Asia is determined to be at the forefront of the AI evolution.
Corporate Development Strategy for Biotech & Pharma Companies
In China, there are more cited papers on AI than in the U. Asia's expanding research capability, availability of investment, and booming innovation centers make the scouting capability a critical skillset to have when involved in collaborating or acquisition opportunities. One of the biggest problems encountered is the cultural barrier that creates a resistance to share innovation and knowledge with other Asian countries — let alone the rest of the world.
Possessing the cultural and language capability to break through these barriers, form partnerships, and commercialize opportunities is imperative.
- Tooling Up: The Business Development Career Track | Science | AAAS?
- Business Development for the Biotechnology and Pharmaceutical Industry - CRC Press Book.
- See a Problem?!
- Martin Austin.